DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Dearnaley DP. et al
Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP trial..
ASCO GU 2020 Abstract 325
Access:
We do not assume any responsibility for the contents of the web pages of other providers.